[Gold treatment of progressive chronic polyarthritis--a clinical study].
In an intraindividual series of investigation consisting of 30 patients with rheumatoid arthritis the effect of gold therapy (Aurothioglucose) has been proved controlling biochemical and clinical parameters. Controls of the function-index by Steinbrocker et al. have shown a significant improvement in comparison with the stage before gold treatment. Futhermore a significant decrease of erythrocyte sedimentation rate (Westergren) as well as a significant increase of albumins and a significant decrease of gamma-globulins in proteinelectrophoresis provoked by gold treatment could be demonstrated. Side effects during gold treatment were observed in 5 patients; therapy was stopped in 2 patients.
D000328:Adult; D000368:Aged; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D006051:Aurothioglucose / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D001797:Blood Protein Electrophoresis; D001799:Blood Sedimentation; D002908:Chronic Disease; D005260:Female; D006046:Gold / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged
D006051:Aurothioglucose; D006046:Gold
Zur Goldbehandlung der progredient chronischen Polyarthritis -- Eine klinische studie